SEVER, B. Et Al. 2016. Indomethacin based new triazolothiadiazine derivatives: Synthesis, evaluation of their anticancer effects on T98 human glioma cell line related to COX-2 inhibition and docking studies. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY , vol.113 , 179-186.

SEVER, B., ALTINTOP, M. D., KUŞ, G., Ozkurt, M., ÖZDEMİR, A., & KAPLANCIKLI, Z. A., (2016). Indomethacin based new triazolothiadiazine derivatives: Synthesis, evaluation of their anticancer effects on T98 human glioma cell line related to COX-2 inhibition and docking studies. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY , vol.113, 179-186.

SEVER, BELGİN Et Al. "Indomethacin based new triazolothiadiazine derivatives: Synthesis, evaluation of their anticancer effects on T98 human glioma cell line related to COX-2 inhibition and docking studies," EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY , vol.113, 179-186, 2016

SEVER, BELGİN Et Al. "Indomethacin based new triazolothiadiazine derivatives: Synthesis, evaluation of their anticancer effects on T98 human glioma cell line related to COX-2 inhibition and docking studies." EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY , vol.113, pp.179-186, 2016

SEVER, B. Et Al. (2016) . "Indomethacin based new triazolothiadiazine derivatives: Synthesis, evaluation of their anticancer effects on T98 human glioma cell line related to COX-2 inhibition and docking studies." EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY , vol.113, pp.179-186.

@article{article, author={BELGİN SEVER Et Al. }, title={Indomethacin based new triazolothiadiazine derivatives: Synthesis, evaluation of their anticancer effects on T98 human glioma cell line related to COX-2 inhibition and docking studies}, journal={EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY}, year=2016, pages={179-186} }